Pieris Pharmaceuticals appoints Tom Bures as CFO, Ahmed Mousa as Chief Business Officer

PALVELLA THERAPEUTICS, INC.

Tom Bures promoted to CFO effective Oct 6, 2021; previously VP Finance and Treasurer.
Ahmed Mousa promoted to Chief Business Officer & General Counsel; previously SVP Corporate Operations and GC.
Bures base salary $370k, Mousa base $385k; each eligible for up to 40% annual bonus.
Severance: 9 months base for without-cause; change of control: 12 months base + target bonus + full vesting.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Thomas Bures

Senior Vice President and Chief Financial Officer

PVLA · PALVELLA THERAPEUTICS, INC.

Effective: 2021-10-06
Filed: October 6, 2021, 7:59 PM ET

the Board appointed Mr. Thomas Bures, the Company’s Vice President, Finance and Treasurer, as Senior Vice President and Chief Financial Officer, effective as of October 6, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas Bures was appointed as Senior Vice President and Chief Financial Officer at PALVELLA THERAPEUTICS, INC..

Action: appointed
Role: Senior Vice President and Chief Financial Officer

Exact text from the filing

the Board appointed Mr. Thomas Bures, the Company’s Vice President, Finance and Treasurer, as Senior Vice President and Chief Financial Officer, effective as of October 6, 2021.

View on SEC.gov

PALVELLA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-21-292635

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.